SEP 08, 2021 9:00 AM PDT

Keynote Presentation: Development of an Affordable COVID-19 Vaccine Based on a Newcastle Disease Virus Platform

C.E. Credits: P.A.C.E. CE Florida CE
Speaker

Abstract

Highly efficacious vaccines against COVD-19 have been generated in a record time, and allowed a great impact in preventing severe disease due to SARS-CoV-2 infection in vaccinated individuals. Unfortunately, the pace in vaccination in developing countries continues to be very slow, mainly due to the lack of vaccine supply. The development of affordable COVID-19 vaccines that can be produced locally to satisfy the needs of developing countries is highly desirable to speed up the world COVID-19 vaccination. We have generated a  COVID-19 vaccine based on a Newcastle disease virus (NDV) vector expressing a stabilized form of the spike (S) protein of SARS-CoV-2.  This vaccine can be manufactured using the same technology in palce for the generation of the annual inactivated influenza virus vaccines,. The NDV-S  vaccine provides high level of protection against SARS-CoV-2 challenge in multiple animal models. Phase 1 clinical trial are being conducted in multiple countries to determine the safety profile and immunogenicity of this novel COVID-19 vaccine.

 

Learning Objectives:

1. To understand viral vector vaccines.

2. To gain knowledge on Newcastle disease virus-based vaccine vectors.

3. To gain knowledge on vaccine development steps

4. To understand the current limitations of COVID-19 vaccines.


Show Resources
You May Also Like
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
SEP 17, 2021 12:00 PM CST
C.E. CREDITS
SEP 17, 2021 12:00 PM CST
Date: September 16, 2021 Time: 9:00pm (PDT), 12:00am (EDT) 3D cellular models like organoids and spheroids offer an opportunity to better understand complex biology in a physiologically rele...
JUN 09, 2021 7:00 AM PDT
C.E. CREDITS
JUN 09, 2021 7:00 AM PDT
Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
NOV 09, 2021 11:00 AM PST
C.E. CREDITS
NOV 09, 2021 11:00 AM PST
Date: November 09, 2021 Time: 11:00am (PDT), 02:00pm (EDT) Clinical translation of human pluripotent stem cells (hPSCs) requires advanced strategies that ensure safe and robust long-term gro...
JUN 08, 2021 9:00 AM PDT
JUN 08, 2021 9:00 AM PDT
Date: June 8, 2021 Time: 9:00am PDT Reducing the spread of highly infectious and deadly diseases within the population, vaccine development is crucial in saving millions of lives each year....
DEC 09, 2021 11:00 AM PST
C.E. CREDITS
DEC 09, 2021 11:00 AM PST
Date: December 09, 2021 Time: 11:00am (PDT), 2:00pm (EDT) The burden of antimicrobial resistance (AMR) has been acknowledged worldwide by leading health institutes. Besides the need for new...
Loading Comments...
Show Resources